Differential response to α-oxoaldehydes in tamoxifen resistant MCF-7 breast cancer cells.

Tamoxifen is the standard adjuvant endocrine therapy for estrogen-receptor positive premenopausal breast cancer patients. However, tamoxifen resistance is frequently observed under therapy. A tamoxifen resistant cell line has been generated from the estrogen receptor positive mamma carcinoma cell li...

Full description

Bibliographic Details
Main Authors: Norbert Nass, Hans-Jürgen Brömme, Roland Hartig, Sevil Korkmaz, Saadettin Sel, Frank Hirche, Aoife Ward, Andreas Simm, Stefan Wiemann, Anne E Lykkesfeldt, Albert Roessner, Thomas Kalinski
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24983248/pdf/?tool=EBI

Similar Items